The brain signature of paracetamol in healthy volunteers: A double-blind randomized trial

16Citations
Citations of this article
47Readers
Mendeley users who have this article in their library.

Abstract

Background: Paracetamol’s (APAP) mechanism of action suggests the implication of supraspinal structures but no neuroimaging study has been performed in humans. Methods and results: This randomized, double-blind, crossover, placebo-controlled trial in 17 healthy volunteers (NCT01562704) aimed to evaluate how APAP modulates pain-evoked functional magnetic resonance imaging signals. We used behavioral measures and functional magnetic resonance imaging to investigate the response to experimental thermal stimuli with APAP or placebo administration. Region-of-interest analysis revealed that activity in response to noxious stimulation diminished with APAP compared to placebo in prefrontal cortices, insula, thalami, anterior cingulate cortex, and periaqueductal gray matter. Conclusion: These findings suggest an inhibitory effect of APAP on spinothalamic tracts leading to a decreased activation of higher structures, and a top-down influence on descending inhibition. Further binding and connectivity studies are needed to evaluate how APAP modulates pain, especially in the context of repeated administration to patients with pain.

Cite

CITATION STYLE

APA

Pickering, G., Kastler, A., Macian, N., Pereira, B., Valabrègue, R., Lehericy, S., … Jean, B. (2015). The brain signature of paracetamol in healthy volunteers: A double-blind randomized trial. Drug Design, Development and Therapy, 9, 3853–3862. https://doi.org/10.2147/DDDT.S81004

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free